The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases (ILM) from colorectal cancer (CRC).
Deepa Magge
No relevant relationships to disclose
Amer H Zureikat
No relevant relationships to disclose
David L. Bartlett
No relevant relationships to disclose
Matthew Peter Holtzman
No relevant relationships to disclose
Haroon Choudry
No relevant relationships to disclose
Jan H. Beumer
No relevant relationships to disclose
Julianne L. Holleran
No relevant relationships to disclose
S. Strychor
No relevant relationships to disclose
James F. Pingpank
No relevant relationships to disclose
Herbert Zeh
No relevant relationships to disclose